Applied Therapeutics Inc expected to post a loss of 16 cents a share - Earnings Preview
06/08/2024 15:01
* Applied Therapeutics Inc APLT.OQ APLT.O is expected
to show
a rise in quarterly revenue when it reports results on August 8
(estimated) for the period ending June 30 2024
* The New York City-based company is expected to report
revenue
of $2.5 million, according to the mean estimate from 4 analysts,
based on LSEG data.
* LSEG's mean analyst estimate for Applied Therapeutics Inc
is
for a loss of 16 cents per share.
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Applied
Therapeutics Inc is $12.00, above its last closing price
of $6.01.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Mar. 31 2024 -0.16 -0.16 -0.67 Missed -320.1
Jan. 1 2024 -0.20 -0.23 -0.34 Missed -49.1
Sep. 30 2023 -0.23 -0.26 -0.47 Missed -81.2
Jun. 30 2023 -0.17 -0.26 -0.37 Missed -39.6
Mar. -0.27 -0.31 -0.18 Beat 41.3
31 2023
Jan. 1 0001 -0.41 -0.46 -0.16 Beat 65.4
Jan. 1 0001 -0.48 -0.48 -0.40 Beat 16.2
Jan. 1 0001 -0.82 -0.78 -0.80 Missed -1.9
This summary was machine generated August 6 at 14:01 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)